Nothing Special   »   [go: up one dir, main page]

PT1446107E - Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso - Google Patents

Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso Download PDF

Info

Publication number
PT1446107E
PT1446107E PT2785239T PT02785239T PT1446107E PT 1446107 E PT1446107 E PT 1446107E PT 2785239 T PT2785239 T PT 2785239T PT 02785239 T PT02785239 T PT 02785239T PT 1446107 E PT1446107 E PT 1446107E
Authority
PT
Portugal
Prior art keywords
adenosylmethionine
tablets
preparation
Prior art date
Application number
PT2785239T
Other languages
English (en)
Inventor
Giuseppe Cianfarani
Original Assignee
Gnosis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis Spa filed Critical Gnosis Spa
Publication of PT1446107E publication Critical patent/PT1446107E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
PT2785239T 2001-11-22 2002-10-18 Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso PT1446107E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI002462A ITMI20012462A1 (it) 2001-11-22 2001-11-22 Processo per la preparazione di compresse comprendenti s-adenosilmetionina

Publications (1)

Publication Number Publication Date
PT1446107E true PT1446107E (pt) 2014-09-12

Family

ID=11448623

Family Applications (1)

Application Number Title Priority Date Filing Date
PT2785239T PT1446107E (pt) 2001-11-22 2002-10-18 Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso

Country Status (12)

Country Link
US (1) US7087587B2 (pt)
EP (1) EP1446107B1 (pt)
JP (1) JP4387192B2 (pt)
KR (1) KR100880511B1 (pt)
CA (1) CA2461576C (pt)
CY (1) CY1116044T1 (pt)
DK (1) DK1446107T3 (pt)
ES (1) ES2497065T3 (pt)
IT (1) ITMI20012462A1 (pt)
PT (1) PT1446107E (pt)
RU (1) RU2313348C2 (pt)
WO (1) WO2003043608A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005298412A (ja) * 2004-04-13 2005-10-27 Minato Pharmaceutical Co Ltd 被覆粒子
ITMI20050485A1 (it) * 2005-03-23 2006-09-24 Truffini & Regge Farmaceutici Formulazioni granulari rivestite
ITMI20060026A1 (it) * 2006-01-10 2007-07-11 Truffini & Regge Farmaceutici Srl Composizioni per uso rale a base di s-adenosilmetionina e processo per il loro ottenimento
ITMI20060629A1 (it) * 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
EP2095828A1 (en) * 2008-02-29 2009-09-02 Gnosis S.p.A. Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease
EP2189154A1 (en) * 2008-11-25 2010-05-26 Gnosis S.p.A. Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
WO2013146687A1 (ja) * 2012-03-30 2013-10-03 ライオン株式会社 S-アデノシルメチオニンおよび/またはその塩を含む組成物
JP6214628B2 (ja) * 2013-04-05 2017-10-18 ライオン株式会社 内服組成物
ITMI20131906A1 (it) * 2013-11-18 2015-05-19 Gnosis Spa Composizioni solide orali a lento rilascio
IT202000006127A1 (it) * 2020-03-23 2021-09-23 Fmc S R L Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028183A (en) * 1973-06-27 1977-06-07 Bioresearch Limited Process of preparing double salts of S-adenosyl-L-methionine
IT8219012A0 (it) 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
IT1229477B (it) 1989-03-13 1991-09-03 Bioresearch Spa Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative
IT1243859B (it) * 1990-10-23 1994-06-28 Bioresearch Spa Composizioni farmaceutiche comprendenti associazioni fra sali di s-adenosil-l-metionina e acido 5-metil (o 5-formil)-tetraidrofolico per la terapia di complicanze neurologiche negli ammalati di aids.
DE19631085A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut
DE19632823C1 (de) * 1996-08-14 1997-11-20 Symbio Herborn Group Gmbh & Co Komplexe zwischen S-(+)-Adenosylmethionin und 3'-Azido-2',3'-didesoxynucleosid als potente Inhibitoren der HIV-Replikation
WO2000012071A2 (de) 1998-08-29 2000-03-09 Miklos Ghyczy Pharmazeutisches und/oder diätetisches produkt
WO2001026646A1 (en) * 1999-10-08 2001-04-19 Pharmnseas, Inc. NUTRACEUTICAL PRODUCTS CONTAINING SAMe AND DIETARY SUPPLEMENTS AND METHOD OF MANUFACTURING AND USE THEREOF
KR100391491B1 (ko) 1999-11-04 2003-07-12 (주)미토콘 미토콘드리아 디엔에이 카피수 증가용 약학 조성물

Also Published As

Publication number Publication date
US7087587B2 (en) 2006-08-08
JP2005514356A (ja) 2005-05-19
KR100880511B1 (ko) 2009-01-28
AU2002350564A1 (en) 2003-06-10
ITMI20012462A1 (it) 2003-05-22
EP1446107B1 (en) 2014-07-23
RU2313348C2 (ru) 2007-12-27
CY1116044T1 (el) 2017-01-25
DK1446107T3 (da) 2014-11-03
CA2461576A1 (en) 2003-05-30
EP1446107A1 (en) 2004-08-18
CA2461576C (en) 2010-06-29
ES2497065T3 (es) 2014-09-22
JP4387192B2 (ja) 2009-12-16
KR20050037499A (ko) 2005-04-22
US20040248843A1 (en) 2004-12-09
WO2003043608A1 (en) 2003-05-30
RU2004118714A (ru) 2005-03-20

Similar Documents

Publication Publication Date Title
IL146389A0 (en) Process for the preparation of dronedarone
EP1432721A4 (en) PROCESS FOR THE PREPARATION OF REBECCAMYCIN AND ANALOGUE THEREOF
HUP0402027A3 (en) Process for the preparation of a xantophyll
GC0000391A (en) Process for the preparation of urea
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
PT1446107E (pt) Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
HUP0302594A3 (en) Process for the preparation of phenethylamine derivatives
IL162385A0 (en) Process for the preparation of echinocandin derivatives
IL153532A0 (en) Process for the preparation of pyrazolopyrimidinones
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
MXPA02006102A (es) Metodo para preparar compuestos bormodifluoroaceticos.
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
PL369718A1 (en) Process for the preparation of (1,4,5)-oxadiazepine derivatives
AU8824201A (en) Process for the preparation of dinapsoline
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
PL373627A1 (en) Process for the preparation of melamine
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
IL164788A0 (en) Process for the preparation of 3-isochromanone
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
EP1186612A4 (en) PROCESS FOR THE PREPARATION OF CYTIDIN DERIVATIVES